SB1821 Summary

• Amends the Anti-Drug Diversion Act to require registrants (medical practitioners) to access and verify central repository information before prescribing or refilling controlled dangerous substances, except for hospice or end-of-life care prescriptions.

• Adds a new category of authorized access to the central repository: federal government-employed medical practitioners, at the discretion of the Oklahoma State Bureau of Narcotics and Dangerous Drugs Control Director.

• Requires registrants to review the information to assess medical necessity and detect unlawful drug-seeking behavior, with documentation placed in patient medical files and protects registrants from liability for reporting such behavior.

• Clarifies that disclosure of central repository information to patients through medical records does not constitute unauthorized disclosure and does not alter professional standards of care.

• Effective date: November 1, 2014.